Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

Most people with risk factors for cardiovascular disease – what are sometimes called the Essential Eight – are managed by primary care clinics, or haven’t seen any provider recently

Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.

An updated rat reference provides more accuracy for research; could help researchers using rat models for the study of DNA, RNA, evolution, or genes linked to disease risks

The new Epigenomic Metabolic Medicine center (EM2C) will contribute to understanding how genetic variations contribute to common, complex diseases such as diabetes

Lung disease specialist comes to Michigan from Vanderbilt University School of Medicine to lead largest department

Cardiologist shares how weight loss medications may impact cardiovascular health.

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.

A large study shows having bipolar disorder is associated with a four- to six-fold risk of dying prematurely, suggesting more preventive efforts needed. Visit Health Lab to read the full story.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.